US health officials on Tuesday recommended “a pause” in the use of Johnson & Johnson’s COVID-19 vaccine to investigate the occurrence of severe cases of blood clots in several people in the United States.
• Read also: All the developments of the pandemic
The US Medicines Agency (FDA) “is investigating six reported cases in the United States of people who developed severe cases of blood clots after receiving the vaccine,” she said in a statement. .
The U.S. Centers for Disease Control and Prevention (CDC), the country’s leading federal public health agency, will meet on Wednesday to assess these cases. The US drug agency will then review their findings.
“While this procedure is ongoing, we recommend a break,” the FDA added.
More than 6.8 million doses of the Johnson & Johnson anti-Covid vaccine have already been administered in the United States and this type of serious side effect appears for the moment “extremely rare”, said health authorities.
The announcement comes as the European Medicines Agency (EMA) said last week it is also investigating links between “J & J’s” vaccine and cases of blood clots.
